Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer

NCT01053546 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2018-08-01

No results posted yet for this study

Summary

RATIONALE: Swallowing exercise therapy may improve the quality of life of head and neck cancer patients undergoing chemotherapy or radiation therapy.

PURPOSE: This randomized phase III trial is studying early onset of swallowing exercise therapy to see how well it works compared to late onset of swallowing exercise therapy in treating patients with head and neck cancer undergoing chemotherapy or radiation therapy.

Conditions

  • Head and Neck Cancer
  • Stage I Hypopharyngeal Cancer
  • Stage I Laryngeal Cancer
  • Stage I Oropharyngeal Cancer
  • Stage II Hypopharyngeal Cancer
  • Stage II Laryngeal Cancer
  • Stage II Oropharyngeal Cancer
  • Stage III Hypopharyngeal Cancer
  • Stage III Laryngeal Cancer
  • Stage III Oropharyngeal Cancer
  • Stage IV Hypopharyngeal Cancer
  • Stage IV Laryngeal Cancer
  • Stage IV Oropharyngeal Cancer

Interventions

BEHAVIORAL

exercise intervention

The early exercise group will start study exercises approximately two weeks prior to the onset of XRT. The late exercise group will start study exercises one month after the completion of XRT. Participants will undergo an initial/pre-radiation and 1-, 3-, 6-, and 12 month post-radiation swallowing assessments.

OTHER

questionnaire administration

Ancillary study

PROCEDURE

quality-of-life assessment

Ancillary study

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Susan Butler · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053546 on ClinicalTrials.gov